Medical
Capstan Medical said a surgeon in Chile had completed the first successful catheter-delivered mitral valve replacements in two patients using its implant and robotics system.
A dated step forward on the record · Company-reported
What the source says
“Capstan Medical today announced the first successful transcatheter mitral valve replacements using its novel implant and surgical robotics system.”
What it means
The company's claim, with no independent confirmation on our record, is that this was the first time a catheter-delivered mitral valve replacement used its system, in two patients in Chile. It is a first-in-human step, so it fits a stage short of paid use. The next entry came in November 2026, when the company reported a first U.S. case. That moved Compass to Pilot. The company also said then that it planned a pivotal trial in 2026.
Compass robotic system, from Capstan Medical, is at stage 3 of 5 on our ladder: pilot. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: A surgeon in the operating room controls it; it doesn't operate on its own.
Written with AI from our record of Compass robotic system and checked against it: every figure appears in that record.
